Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
BackgroundGlioblastoma multiforme (GBM) is the most lethal brain cancer in adults, characterized by rapid growth, extensive invasiveness, and poor prognosis, and there is still a lack of effective treatments. Here, we aimed to explore the role of triptolide (TPL), purified from Tripterygium wilfordi...
Main Authors: | Chao Yuan, Yanli Liao, Shengjie Liao, Mi Huang, Duanzhuo Li, Weibin Wu, Yi Quan, Liqiang Li, Xin Yu, Wenxia Si |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1077640/full |
Similar Items
-
A review on lipase-catalyzed synthesis of geranyl esters as flavor additives for food, pharmaceutical and cosmetic applications
by: YuQi Liu, et al.
Published: (2022-10-01) -
Mechanistic insights into nitrogen-induced changes in pasting characteristics of rice during storage based on proteomics analysis
by: Hanling Liang, et al.
Published: (2023-12-01) -
Effect of ethanol osmotic dehydration on CO2 puffing and drying mechanism of potato
by: Yao Niu, et al.
Published: (2023-06-01) -
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
by: Thomas F. Eleveld, et al.
Published: (2023-02-01) -
Additive prognostic impact of the cerebrospinal fluid arginine/ornithine ratio to established clinical scores in aneurysmal subarachnoid hemorrhage
by: Johannes Weller, et al.
Published: (2023-04-01)